Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies
Paul T. Scott(Walter Reed Army Institute of Research), Sheila A. Peel(Henry M. Jackson Foundation), David M. Brett‐Major(Apple (Israel)), Clinton K. Murray(Joint Commission), Laura A. Pacha(Naval Medical Research Command), Adam W. Armstrong(Uniformed Services University of the Health Sciences), Jennifer Malia(Walter Reed Army Institute of Research), Shilpa Hakre(Walter Reed Army Institute of Research), Nelson L. Michael(Walter Reed Army Institute of Research), Roland L Fahie, Francisco J. Rentas, Michael A. Forgione, Hala H. Maktabi(Naval Medical Research Command), Aatif M. Hayat(Naval Medical Research Command), Robert Cohen(Association Clinique et Thérapeutique Infantile du Val de Marne), Charmagne Beckett(United States Department of the Army), Steven B. Cersovsky(United States Army Medical Command), Jason M Blaylock, Jason F. Okulicz(Gilead Sciences (United States)), Beth Blackwell(Emmes (United States)), Stephen A. Harrison(Pinnacle Clinical Research), Linda L. Jagodzinski(Walter Reed Army Institute of Research), Peter Dawson(Emmes (United States)), Angelia A Eick-Cost(Henry M. Jackson Foundation)
Cited by 3
Related Papers
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
|New England Journal of Medicine|2009|3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k